Kathiresan Sekar, CEO of Verve Therapeutics ($VERV), sold shares once on the open market in the last year, totaling $40,761. His most recent sale occurred on April 2, 2025. These sales rank 10,586th among 11,678 insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. Sekar made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 22, 2025 | Maze Therapeutics, Inc. | $MAZE | Kathiresan Sekar | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | U | Common Stock | 348431 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.39% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | U | Common Stock | 240997 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.27% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Stock Option (right to buy) | 488000 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.55% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Stock Option (right to buy) | 150000 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.17% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Restricted Stock Units | 120000 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.13% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Restricted Stock Units | 99000 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.11% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Stock Option (right to buy) | 138995 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.16% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Stock Option (right to buy) | 167425 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.19% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Stock Option (right to buy) | 500203 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.56% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Stock Option (right to buy) | 75105 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.08% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Stock Option (right to buy) | 431988 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.48% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | D | Stock Option (right to buy) | 526000 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.59% |
| July 25, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | U | Common Stock | 110997 | $0.00 | 0.0000 | 89,143,237 | 100.00% | 0.12% |
| June 6, 2025 | Relay Therapeutics, Inc. | $RLAY | Kathiresan Sekar | Not found | A | Stock Option (Right to Buy) | 136681 | $0.00 | 136,681.0000 | 169,521,849 | 9999.99% | 0.08% |
| April 2, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | S | Common Stock | 9822 | $4.15 | 698,680.0000 | 88,795,768 | 1.39% | 0.01% |
| April 1, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | M | Common Stock | 33000 | $0.00 | 708,502.0000 | 88,795,768 | 4.89% | 0.04% |
| April 1, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | M | Restricted Stock Units | 33000 | $0.00 | 99,000.0000 | 88,795,768 | 25.00% | 0.04% |
| Jan. 8, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | A | Stock Option (right to buy) | 488000 | $0.00 | 488,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 8, 2025 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | A | Restricted Stock Units | 120000 | $0.00 | 120,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 4, 2024 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | G | Common Stock | 30000 | $0.00 | 675,502.0000 | 0 | 4.25% | 0.00% |
| Dec. 4, 2024 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | G | Common Stock | 30000 | $0.00 | 675,502.0000 | 0 | 4.65% | 0.00% |
| June 28, 2024 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | M | Stock Option (right to buy) | 30000 | $0.00 | 575,308.0000 | 0 | 4.96% | 0.00% |
| June 28, 2024 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | M | Common Stock | 30000 | $2.87 | 673,122.0000 | 0 | 4.66% | 0.00% |
| June 3, 2024 | Relay Therapeutics, Inc. | $RLAY | Kathiresan Sekar | Not found | A | Stock Option (Right to Buy) | 102225 | $0.00 | 102,225.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | A | Stock Option (right to buy) | 526000 | $0.00 | 526,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Verve Therapeutics, Inc. | $VERV | Kathiresan Sekar | Chief Executive Officer | A | Restricted Stock Units | 132000 | $0.00 | 132,000.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2023 | Relay Therapeutics, Inc. | $RLAY | Kathiresan Sekar | Director | A | Stock Option (Right to Buy) | 66055 | $0.00 | 66,055.0000 | 0 | 9999.99% | 0.00% |